Investment

Deal of the Week: Family co-invest group works with biotech fund

The coronavirus has focused investors attention on biotech/healthcare. Family Capital’s Deal of the Week reflects this trend, and for the third week in a row, we are highlighting another deal in the sector. 

Subscribe

You will need a Premium+ Subscription to read this article.

Exclusive news, analysis and research on global family enterprise and private investment offices

SUBSCRIBE TODAY

Already have an account? Sign in

You need a Premium subscription.

To read Premium articles please subscribe.

SUBSCRIBE TODAY

Already have an account? Sign in

You've reached the end.

Continue reading free articles by registering as a Member.
Or choose a Premium Plan.

SUBSCRIBE TODAY

Already have an account? Sign in

What to read next

Premium

Series A and C dominate deals this week, which include a novel fire protection group, five Swedish family offices backing a fintech platform, and one prominent family office backing an advertising/marketing…
Premium

A hydrogen-led clean energy group that has invented a means of neutralizing carbon emissions from natural gas production has received funding from three family offices and a huge Japanese conglomerate
Investment

Two family offices have co-invested in an alternative healthcare group which a prominent alternative medicine proponent backs

Leave a Reply